The Digital Implementation of What We Have Learned about Learning in General Chemistry

Today’s Webchat will explore best technologies for controlling NOx emissions, specifically the use of Selective Catalytic Reduction (SCR) and Selective Non-Catalytic Reduction (SNCR).

In this webinar, we will explore best practice approaches for seamless handover at critical junctures en route to commercial manufacturing of small molecule drugs. One of the biggest challenges in today's small molecule drug development are the different requirements on quality and supply chain going from exploratory research to commercial manufacturing. A key risk to consider is the over- and/or underengineering of chemical specialties for drug synthesis leading to higher total cost of ownership.

Before marketing a new chemical, the manufacturer/importer, in order to meet the various national and international legal requirements, has to submit information in the form of a notification or registration (e.g. phys-chem, toxicological, ecotoxicological data) to support each Government’s risk assessment to determine whether the substance poses an unreasonable risk to the environment and/or human health. Some countries require pre-manufacture/import notification while for many jurisdictions, the chemical notification process is a tiered system requiring subsequent notifications as the annual amount of the imported or manufactured substance increases. Further, there are expanding global initiatives to assess chemicals already in the marketplace and subsequently take action on any chemicals found to be harmful to human health and/or the environment.

Polyurethane (PU) adhesives, sealants and binders are used in a variety of structural and non-structural applications.